Data gathered: April 15
AI Stock Analysis - Aura Biosciences (AURA)
Analysis generated April 17, 2024. Powered by Chat GPT.
Aura Biosciences is a biotech company at the forefront of fighting cancer through the development of novel targeted therapies. Their commitment to innovation and patient care has differentiated them as a leader in their niche. Offering a valuable pipeline of therapeutics, Aura Biosciences is focused on addressing unmet needs in oncology, with a particular emphasis on ocular melanoma. By employing advanced technology and groundbreaking research, Aura Biosciences aims to deliver products that improve patient outcomes significantly.
Stock Alerts - Aura Biosciences (AURA)
 |
Aura Biosciences | April 10 Price is down by -5.4% in the last 24h. |
|
Aura Biosciences | April 9 Price is up by 6% in the last 24h. |
|
Aura Biosciences | April 8 Price is down by -5.6% in the last 24h. |
|
Aura Biosciences | April 3 Price is down by -5.6% in the last 24h. |
Alternative Data for Aura Biosciences
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 3 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 4,000 | Sign up | Sign up | Sign up |
| Employee Rating | 84 | Sign up | Sign up | Sign up |
| Google Trends | 8 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 171 | Sign up | Sign up | Sign up |
| Twitter Followers | 587 | Sign up | Sign up | Sign up |
| Twitter Mentions | 1,446 | Sign up | Sign up | Sign up |
| News Mentions | 2 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 73 | Sign up | Sign up | Sign up |
| Linkedin Employees | 114 | Sign up | Sign up | Sign up |
About Aura Biosciences
Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer.
| Price | $5.45 |
| Target Price | Sign up |
| Volume | 186,050 |
| Market Cap | $266M |
| Year Range | $4.97 - $11.74 |
| Dividend Yield | 0% |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
Wellington Management Group LLP Grows Holdings in Aura Biosciences, Inc. (NASDAQ:AURA)April 14 - ETF Daily News |
|
Brokerages Set Aura Biosciences, Inc. (NASDAQ:AURA) Price Target at $22.75April 13 - ETF Daily News |
|
American Century Companies Inc. Has $392,000 Stock Holdings in Aura Biosciences, Inc. (NASDAQ:AURA)April 13 - ETF Daily News |
|
Leerink Partnrs Has Bearish Outlook for AURA Q1 EarningsApril 11 - ETF Daily News |
 |
Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?April 6 - Yahoo Entertainment |
 |
Aura Biosciences appoints Bitetti to board of directorsApril 2 - Thefly.com |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 2.3M | 6.2M | -3.9M | -21M | -23M | -0.420 |
| Q2 '24 | 2.5M | 5.9M | -3.4M | -20M | -22M | -0.410 |
| Q1 '24 | 2.7M | 5.3M | -2.6M | -20M | -22M | -0.400 |
| Q4 '23 | 2.4M | 4.5M | -2.1M | -22M | -24M | -0.560 |
| Q3 '23 | 2M | 5.1M | -3.1M | -19M | -19M | -0.480 |
Insider Transactions View All
| Hopkins Janet Jill filed to sell 269,794 shares at $7.8. February 18 '25 |
| Elazzouzi Amy filed to sell 82,278 shares at $7.8. February 18 '25 |
| Plavsic Mark filed to sell 209,456 shares at $7.8. February 18 '25 |
| De Los Pinos Elisabet filed to sell 482,440 shares at $7.8. February 18 '25 |
| Elazzouzi Amy filed to sell 38,442 shares at $7.7. January 21 '25 |
Similar companies
Read more about Aura Biosciences (AURA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Aura Biosciences?
The Market Cap of Aura Biosciences is $266M.
What is the current stock price of Aura Biosciences?
Currently, the price of one share of Aura Biosciences stock is $5.45.
How can I analyze the AURA stock price chart for investment decisions?
The AURA stock price chart above provides a comprehensive visual representation of Aura Biosciences' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Aura Biosciences shares. Our platform offers an up-to-date AURA stock price chart, along with technical data analysis and alternative data insights.
Does AURA offer dividends to its shareholders?
As of our latest update, Aura Biosciences (AURA) does not offer dividends to its shareholders. Investors interested in Aura Biosciences should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Aura Biosciences?
Some of the similar stocks of Aura Biosciences are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.